Jump to navigation
DENVER – The implementation of personalized health care in cancer relies on the identification and characterization of cancer biomarkers and the av
DENVER – Personalized medicine in lung cancer relies on the identification and characterization of cancer biomarkers and the availability of accura
DENVER – Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC).
DENVER – The incidence of lung cancer in women affects an estimated 516,000 women worldwide, of which 100,000 are in the United States and 70,000 i
DENVER – ALK rearrangement has been demonstrated to be a potent oncogenic driver and a promising therapeutic target in non-small cell lung cancer (
DENVER – Most lung cancers are detected when patients become symptomatic and have latestage disease.
Join the only international association solely dedicated to lung cancer research and treatment.
The IASLC’s premier journal, emphasizing a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews and opinion pieces. Visit JTO
IASLC 40th Anniversary Page